Evidence map›Paper›PMID 41541907›Full record

ArticleIJU case reports2026

Renal Granuloma Distinct From the Renal Pelvis Following Bacillus Calmette-Guérin Treatment for Bladder Cancer: A Case Report.

Ryuji Oka, Yusuke Goto, Kosuke Mikami, Hiroto Kato, Ken Wakai, Kyokushin Hou, Kazuhiro Araki, Takashi Fujino, Kazuto Yamazaki, Yukio Naya

Abstract read
In one paragraph

Article in IJU case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ryuji OkaDepartment of Urology Teikyo University Chiba Medical Center Chiba Japan.
Yusuke GotoDepartment of Urology Teikyo University Chiba Medical Center Chiba Japan.ORCID https://orcid.org/0000-0001-7720-9740
Kosuke MikamiDepartment of Urology Teikyo University Chiba Medical Center Chiba Japan.
Hiroto KatoDepartment of Urology Teikyo University Chiba Medical Center Chiba Japan.
Ken WakaiDepartment of Urology Teikyo University Chiba Medical Center Chiba Japan.
Kyokushin HouDepartment of Urology Teikyo University Chiba Medical Center Chiba Japan.
Kazuhiro ArakiDepartment of Urology Teikyo University Chiba Medical Center Chiba Japan.
Takashi FujinoDepartment of Pathology Teikyo University Chiba Medical Center Chiba Japan.
Kazuto YamazakiDepartment of Pathology Teikyo University Chiba Medical Center Chiba Japan.
Yukio NayaDepartment of Urology Teikyo University Chiba Medical Center Chiba Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The incidence of renal complication following BCG treatment is rare. Few previous studies have reported a solitary renal granuloma distinct from the renal pelvis following BCG treatment. Case Presentation: An 85-year-old male underwent transurethral resection of the bladder tumor. A 6-week induction of intravesical BCG instillation therapy was planned; however, the sixth instillation was canceled owing to fever. Regular follow-up revealed no recurrence. However, 4 years later, CT revealed a right renal mass. With a clinical diagnosis of renal cell carcinoma, robot-assisted partial nephrectomy was performed. The pathological diagnosis was epithelioid cell granuloma with caseating necrosis. Stress cystography revealed no vesicoureteral reflux. Conclusion: A renal granuloma caused by BCG is one of the differential diagnoses for solitary renal mass following BCG treatment, even if the mass is not adjacent to the renal pelvis.

Indexed as

BCGbladder cancerRAPNrenal granulomarenal tumor

Identifiers

PMID41541907
PMCPMC12803747

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.